CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-two ...

CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price decreased by Citigroup from $89.00 to $82.00 in a report ...

The consensus price target for CRISPR Therapeutics AG (NASDAQ:CRSP) has been adjusted from $72.75 to $65, reflecting changes in financial performance and industry developments. Despite a quarterly ...

Highlights,CRISPR Therapeutics has seen price adjustments from financial firms, reflecting shifts in market expectations.,The ...

The First Trust Mid Cap Value AlphaDEX ETF (FNK) made its debut on 04/19/2011, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - Mid Cap Value category of the ...

Wolfe Research lowered shares of Robinhood Markets (NASDAQ:HOOD – Free Report) from an outperform rating to a peer perform ...

JP Morgan analyst Matthew Boss upgraded the rating for Bath & Body Works, Inc. BBWI from Neutral to Overweight and boosted ...

Citi analyst Yigal Nochomovitz maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price target of ...

Citi analyst Yigal Nochomovitz lowered the firm’s price target on Crispr Therapeutics (CRSP) to $82 from $89 and keeps a Buy rating on the ...

BJ’s Wholesale Club Holdings, Inc. (NYSE:BJ – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seventeen brokerages that are currently covering the company, Marketbeat ...

ARC Resources Ltd. (TSE:ARX – Get Free Report) has received a consensus rating of “Buy” from the eight analysts that are presently covering the company, MarketBeat reports. Seven equities research ...

Trane Technologies plc (NYSE:TT – Get Free Report) has been given a consensus rating of “Hold” by the seventeen research firms that are currently covering the firm, MarketBeat reports. One analyst has ...